Chemoinformaics analysis of 2-Phenylethyl pivalate
| Molecular Weight | 206.285 | nRot | 3 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 11 |
| Exact Molecular Weight | 206.131 | nRing | 1 |
| Solubility: LogS | -5.389 | nHRing | 0 |
| Solubility: LogP | 4.689 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 35.3163 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.586 |
| Synth | 4.079 |
| Natural Product Likeliness | 2.489 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.133 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.494 |
| MDCK | 0.0000109 |
| BBB | 0.76 |
| PPB | 0.965036 |
| VDSS | 2.711 |
| FU | 0.0299783 |
| CYP1A2-inh | 0.178 |
| CYP1A2-sub | 0.655 |
| CYP2c19-inh | 0.289 |
| CYP2c19-sub | 0.953 |
| CYP2c9-inh | 0.507 |
| CYP2c9-sub | 0.405 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.119 |
| CYP3a4-inh | 0.483 |
| CYP3a4-sub | 0.821 |
| CL | 15.654 |
| T12 | 0.159 |
| hERG | 0.029 |
| Ames | 0.025 |
| ROA | 0.08 |
| SkinSen | 0.718 |
| Carcinogencity | 0.655 |
| EI | 0.616 |
| Respiratory | 0.774 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.613477 |